DYN financials
Dyne Therapeutics (DYN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
DYN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$2.05M | -$468.18M | -$446.21M | -3.47 |
| 2024 | $0.00 | -$2.24M | -$343.89M | -$317.42M | -3.37 |
| 2023 | $0.00 | -$2.46M | -$242.16M | -$235.94M | -3.95 |
| 2022 | $0.00 | $0.00 | -$170.96M | -$168.10M | -3.23 |
| 2021 | $0.00 | $0.00 | -$150.03M | -$149.29M | -2.93 |
| 2020 | $0.00 | -$700.00K | -$58.65M | -$58.74M | -1.24 |